v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current    
Cash $ 1,558 $ 26,703
Advances receivable 2,851 18,991
Total current assets 4,409 45,694
Total assets 4,409 45,694
Current    
Accounts payable 81,570 107,212
Accrued liabilities 142,612 97,419
Due to related parties 986,146 815,463
Total current liabilities 1,210,328 1,020,094
Loan 0 26,874
Total liabilities 1,210,328 1,046,968
SHAREHOLDERS' DEFICIENCY    
Authorized 500,000,000 Common Shares, $0.0008 per share par value Issued and outstanding 38,906,742 Common Shares (December 31, 2023 - 38,906,742) 31,125 31,125
Additional paid-in capital 43,325,272 43,325,272
Deficit accumulated during the exploration stage (44,562,316) (44,357,671)
Total shareholders' deficiency (1,205,919) (1,001,274)
Total liabilities and shareholders' deficiency $ 4,409 $ 45,694